uniQure N.V. Target Price

See uniQure N.V.'s analyst price targets ($61) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.46

Average Target Price

$60.82

159.2% upside

11 analysts in the last 4 months

High: $80 | Low: $31

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-02	RBC CapitalLuca Issi	$48	104.6% upside
2026-09-30	Goldman Sachs	$31	32.1% upside
2026-09-29	Wells Fargo	$75	219.7% upside
2026-07-30	Barclays	$60	155.8% upside
2026-06-29	H.C. Wainwright	$80	241% upside
2026-06-25	Mizuho SecuritiesUy Ear	$68	189.9% upside
2026-06-18	RBC Capital	$65	177.1% upside
2026-06-18	Barclays	$65	177.1% upside
2026-06-18	Leerink PartnersJoseph Schwartz	$70	198.4% upside
2026-06-18	Goldman SachsSalveen Richter	$46	96.1% upside
2026-06-17	Cantor Fitzgerald	$61	160% upside
2026-05-06	H.C. WainwrightPatrick Trucchio	$50	113.1% upside
2026-05-05	Stifel NicolausPaul Matteis	$28	19.4% upside
2026-04-30	Chardan Capital	$37	57.7% upside
2026-04-20	Goldman Sachs	$10	57.4% downside
2026-03-09	Chardan CapitalDaniil Gataulin	$31	32.1% upside
2026-03-09	Wells FargoYanan Zhu	$60	155.8% upside
2026-03-09	RBC CapitalLuca Issi	$35	49.2% upside
2026-03-02	Leerink PartnersJoseph Schwartz	$35	49.2% upside
2026-03-02	RBC CapitalLuca Issi	$11	53.1% downside
2026-03-02	Stifel NicolausPaul Matteis	$14	40.3% downside
2026-01-27	Barclays	$31	32.1% upside
2025-12-11	Stifel Nicolaus	$40	70.5% upside
2025-12-08	Mizuho SecuritiesUy Ear	$33	40.7% upside
2025-11-04	H.C. WainwrightPatrick Trucchio	$70	198.4% upside
2025-11-04	Goldman Sachs	$38	62% upside
2025-11-03	Chardan CapitalDaniil Gataulin	$53	125.9% upside
2025-11-03	RBC Capital	$45	91.8% upside
2025-10-06	H.C. Wainwright	$110	368.9% upside
2025-10-02	Wells Fargo	$80	241% upside
2025-09-25	UBS	$95	304.9% upside
2025-09-25	Mizuho SecuritiesUy Ear	$60	155.8% upside
2025-07-30	Cantor Fitzgerald	$47	100.3% upside
2025-07-29	Chardan Capital	$35	49.2% upside
2025-02-28	Wells Fargo	$30	27.9% upside
2025-01-07	RBC CapitalLuca Issi	$24	2.3% upside
2022-11-23	Goldman Sachs	$57	143% upside
2022-08-08	Chardan CapitalMatthew Barcus	$60	155.8% upside
2022-05-03	Credit Suisse	$51	117.4% upside
2022-01-07	Wells FargoYanan Zhu	$34	44.9% upside
2021-12-16	Raymond JamesDanielle Brill	$58	147.2% upside
2021-10-28	JefferiesSuji Jeong	$62	164.3% upside

uniQure N.V. (QURE) FAQ

uniQure N.V. (QURE) currently reports a target price of $61. Use the charts on this page to explore uniQure N.V.'s target price history and peer comparisons.

Analysts' average 12-month price target for uniQure N.V. is $61, about 159.2% upside from the current share price of $23.46. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $61, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for uniQure N.V., and consider following QURE for alerts when major investors trade the stock.

uniQure N.V. is classified in the Healthcare sector. On target price, it currently shows $61. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing QURE with unrelated industries.